GAUSH MEDITECH (02407): Gaush Innovation Receives CE Certificate for Corneal Confocal Microscope.
High Vision Medical (02407) announced that its subsidiary, High Vision Innovative Technology Co., Ltd. (High Vision Innovation), recently officially received the Cornea Co-polymerization Microscope CE certificate issued by DEKRA (certificate number: 6208923CE01). The acquisition of this important qualification signifies that the company's cornea co-polymerization microscope fully complies with the strict standards of the EU MDR regulations, and its technological strength has gained international recognition. This not only lays a solid foundation for the company to expand global sales and international development, but also establishes a strategic position in the international high-end ophthalmic medical market based on high standard products and core technological strength.
GAUSH MEDITECH (02407) announced that its subsidiary, Gaoshichuangxin Technology Co., Ltd. (Gaoshichuangxin), recently officially obtained the corneal confocal microscopes CE registration certificate issued by DEKRA (Certificate No.: 6208923CE01). The acquisition of this important qualification signifies that the company's corneal confocal microscopes fully comply with the strict standards of the EU MDR regulations, and its technological strength has received international recognition. This not only establishes a solid foundation for the company to expand global sales and international development but also solidifies its strategic position in the international high-end ophthalmic medical market based on high-standard products and hardcore technological strength.
DEKRA, founded in 1925, is a globally leading independent non-listed professional inspection and certification organization covering a wide range of industries.
The EU CE certification is a mandatory qualification for medical devices to enter the European market, demonstrating compliance with EU MDR regulations. It not only focuses on product safety and performance but also emphasizes risk management and clinical evaluation throughout the product lifecycle. Through CE certification, it means that the company's products meet EU unified standards in various stages such as design and development, production, clinical validation, and post-market surveillance, making it one of the highest recognized entry thresholds in the global medical device market.
Related Articles

On April 10, HORIZONROBOT-W (09660) spent 452,000 Hong Kong dollars to repurchase 64,200 shares.

Chairman of Shanghai Orient-Chip Technology (688061.SH) proposes to repurchase company shares with a total amount ranging from 16 million to 32 million RMB.

Lotus Technology (LOT.US) 2025 Financial Report: Loss narrows by 46%, driven by globalization and service revenue growth, improving growth quality.
On April 10, HORIZONROBOT-W (09660) spent 452,000 Hong Kong dollars to repurchase 64,200 shares.

Chairman of Shanghai Orient-Chip Technology (688061.SH) proposes to repurchase company shares with a total amount ranging from 16 million to 32 million RMB.

Lotus Technology (LOT.US) 2025 Financial Report: Loss narrows by 46%, driven by globalization and service revenue growth, improving growth quality.

RECOMMEND





